Zdrowie i gospodarka · 11/06/2018
FDA Renews Pharmacy Compounding Advisory Committee Charter for 2 Years
The FDA has renewed the Pharmacy Compounding Advisory Committee charter for an additional 2 years, with the new term set to expire on April 25, 2020, following a determination by the Commissioner of Food and Drugs that it is in the public interest to do so.